首页> 外文学位 >Behavioral pharmacology of dopamine D2 and D3 receptor agonists and antagonists in rats.
【24h】

Behavioral pharmacology of dopamine D2 and D3 receptor agonists and antagonists in rats.

机译:大鼠多巴胺D2和D3受体激动剂和拮抗剂的行为药理学。

获取原文
获取原文并翻译 | 示例

摘要

Dopamine D2-like receptors are involved in the regulation of a variety of behaviors, and have proven to be important pharmacologic targets for the treatment of diseases such as Parkinson's disease, schizophrenia, restless leg syndrome, and depression, however, the receptor(s) responsible for the therapeutic and behavioral effects have yet to be elucidated. Identification of behaviors specifically mediated by the D2 and/or D3 receptors would not only provide insight into the receptor(s) mediating these therapeutic and behavioral effects, but it would also aid in the evaluation of novel D2-like agonists and antagonists. These studies were primarily aimed at the pharmacologic evaluation of the hypothesis that the induction of yawning by D2-like agonists is mediated by a specific activation of the D3 receptor, while the inhibition of yawning observed at higher doses is mediated by a concomitant activation of the D2 receptor.;Convergent evidence from the effects of D2-like agonists alone, and in combination with a series of D2-like antagonists support this general hypothesis. All D3-preferring agonists elicited dose-dependent yawning behavior resulting in a characteristic inverted U-shaped dose-response curve. These functions were differentially modulated by D3- and D2-preferring antagonists, with D3-preferring antagonists producing selective rightward shifts of the ascending limb, and D2-preferring antagonists producing selective shifts of the descending limb. The selectivity of these effects was confirmed by a comparison of the relative potencies of D2- and D3-preferring agonists to induce yawning and hypothermia (a well validated D2-mediated effect), as well as the relative potencies of D2- and D3-preferring antagonists to inhibit the induction of yawning and hypothermia by D2-like agonists. Similar comparisons of the effects of D2-like agonists and antagonists on the induction of yawning and penile erection not only provided further support for the differential roles of the D3 and D 2 receptors in the regulation of yawning, but suggest that D2-like agonist-induced yawning and penile erection are similarly mediated by the D3 (induction) and D2 (inhibition) receptors in rats. These studies not only provide strong pharmacologic evidence for a specific D3-mediated behavior, but have also allowed for the identification of other D3-mediated behaviors and determinations of in vivo D2/D3 selectivity.
机译:多巴胺D2样受体参与多种行为的调节,并且已被证明是治疗帕金森氏病,精神分裂症,不安腿综合征和抑郁症等疾病的重要药理靶标,但是,该受体尚未阐明造成治疗和行为影响的原因。鉴定由D2和/或D3受体特异性介导的行为,不仅可以洞悉介导这些治疗和行为作用的受体,还可以帮助评估新型D2类激动剂和拮抗剂。这些研究主要针对以下假设的药理学评估:D2样激动剂诱导打哈欠是由D3受体的特异性激活介导的,而在较高剂量下观察到的对打哈欠的抑制作用是由D3受体的伴随激活介导的。 D2受体。来自单独的D2样激动剂以及与一系列D2样拮抗剂结合使用的综合证据支持这一一般假设。所有D3优先激动剂均引起剂量依赖性打呵欠行为,从而形成特征性的倒U型剂量反应曲线。这些功能受到D3和D2优先拮抗剂的调节,其中D3优先拮抗剂产生上升的肢体选择性向右移位,D2优先拮抗剂产生下降的肢体选择性移位。通过比较D2和D3优先激动剂诱导打哈欠和体温过低的相对效能(一种经过充分验证的D2介导的作用)以及D2和D3优先相对的相对效能,证实了这些效应的选择性。拮抗剂可抑制D2样激动剂诱导的打哈欠和体温过低。 D2样激动剂和拮抗剂对诱导打哈欠和阴茎勃起的作用的类似比较不仅为D3和D 2受体在打哈欠的调节中的不同作用提供了进一步的支持,而且表明D2样激动剂-诱导的打哈欠和阴茎勃起类似地由大鼠中的D3(诱导)和D2(抑制)受体介导。这些研究不仅为特定的D3介导的行为提供了强大的药理证据,而且还允许鉴定其他D3介导的行为和确定体内D2 / D3的选择性。

著录项

  • 作者

    Collins, Gregory T.;

  • 作者单位

    University of Michigan.;

  • 授予单位 University of Michigan.;
  • 学科 Health Sciences Pharmacology.
  • 学位 Ph.D.
  • 年度 2008
  • 页码 194 p.
  • 总页数 194
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号